In vitro reconstitution of B cell receptor-antigen interactions to evaluate potential vaccine candidates.

Weaver, Grant C; Villar, Rina F; Kanekiyo, Masaru; Nabel, Gary J; Mascola, John R; Lingwood, Daniel

Weaver, Grant C; Villar, Rina F; Kanekiyo, Masaru; Nabel, Gary J; Mascola, John R; Lingwood, Daniel.

Afiliação

Weaver GC; The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute for Technology and Harvard University, Cambridge, Massachusetts, USA.
Villar RF; The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute for Technology and Harvard University, Cambridge, Massachusetts, USA.
Kanekiyo M; Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Nabel GJ; Sanofi, Cambridge, Massachusetts, USA.
Mascola JR; Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Lingwood D; The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute for Technology and Harvard University, Cambridge, Massachusetts, USA.

Nat Protoc ; 11(2): 193-213, 2016 Feb.

Article em En | MEDLINE | ID: mdl-26741406

Assuntos

Antígenos/metabolismo; Linfócitos B/imunologia; Receptores de Antígenos de Linfócitos B/metabolismo; Vacinas/imunologia; Linhagem Celular; Humanos; Ligação Proteica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Linfócitos B / Receptores de Antígenos de Linfócitos B / Antígenos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google